Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Smith, Danny
DOB:	24-DEC-1982 (Age: 43)
Gender:	male
Address:	Studio 6 Ford centers SW1A London (United Kingdom)
ID:	7706-924408-3 (ECI)

Report
Date:	10-MAR-2018

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Evelina Children's Hospital SE1 7 London (United Kingdom)

Specimen
Collected:	10-MAR-2018

Chemistry

Test	10-MAR-2018	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.4 H	4.0 - 5.6	%
Glucose [Mass/volume] in Blood	98.6	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	17.5	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.4 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	10.0	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.9	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	3.7	3.5 - 5.0	mmol/L
Chloride [Moles/volume] in Blood	107.8 H	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	21.5 L	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	177.5	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	145.4	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	97.4	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	51.0	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating impaired glucose control (prediabetes/early diabetes). Creatinine is slightly high, suggesting possible mild renal impairment. Chloride is marginally elevated and CO₂ is slightly low, which may reflect mild metabolic acidosis. Lipid profile is within acceptable limits. Recommend further evaluation of glycemic control and renal function, and clinical correlation for acid-base status.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated HbA1c, indicating impaired glucose control (prediabetes/early diabetes). Creatinine is slightly high, suggesting possible mild renal impairment. Chloride is marginally elevated and CO₂ is slightly low, which may reflect mild metabolic acidosis. Lipid profile is within acceptable limits. Recommend further evaluation of glycemic control and renal function, and clinical correlation for acid-base status.